Di Nuzzo Private Wealth, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Di Nuzzo Private Wealth, Inc.
- $579 Million
- Q2 2024
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 10 shares of REGN stock, worth $10,128. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10
Previous 9
11.11%
Holding current value
$10,128
Previous $8,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding REGN
# of Institutions
1,464Shares Held
84.4MCall Options Held
907KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$9.11 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$8.55 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$8.38 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$4.9 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$4.7 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $109B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...